CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 216 enrolled
Drug / intervention
Radiofrequency ablationprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01008657
NCT01008657N/ACompleted
CompareCT.gov

Multipolar Radiofrequency Ablation for the Treatment of Hepatocellular Carcinoma Using Classical Intranodular Technique Versus Extra Nodular Technique So-called "No Touch" Technique: A Prospective Randomized Trial

Assistance Publique - Hôpitaux de Paris·interventional·Posted Nov 6, 2009·Updated Aug 29, 2017

In Brief

A clinical study evaluating Radiofrequency ablation for Hepatocellular Carcinomas. Completed, enrolled 216 participants across 1 site.

Detailed Summary

The primary purpose of the trial is to demonstrate that at least a 40% drop of recurrence rate can be achieve in hepatocellular carcinoma patients treated with no touch multipolar radiofrequency ablation technique compared to those treated with usual intranodular multipolar technique.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHepatocellular Carcinomas
CountriesFrance
Collaborators--

Timeline

N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedNov 6, 2009
Enrollment StartFeb 9, 2010
Primary CompletionOct 6, 2016
TodayJul 2, 2026
Enrollment to primary: 6.7 yearsPosted 16.7 years ago

Interventions

Radiofrequency ablationprocedure

Percutaneous multipolar radiofrequency ablation.